Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Orsolini

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
BMC Rheumatology|September 10, 2024
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritisGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|July 12, 2018
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitisGiovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Pharmacological Research|July 16, 2019
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritisGiovanni Orsolini, Angelo Fassio, Maurizio Rossini, et al.
Cancers|December 24, 2021
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM NetworkRoberta Zanotti, Massimiliano Bonifacio, Cecilia Isolan, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Clinical and Experimental Rheumatology|December 2, 2014
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral densityMaurizio Rossini, Ombretta Viapiana, Silvano Adami, et al.
Clinical and Experimental Rheumatology|October 3, 2019
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunctionGiovanni Cioffi, Alessandro Giollo, Giovanni Orsolini, et al.
The American Journal of Medicine|June 24, 2014
Zoledronic acid in osteoporosis secondary to mastocytosisMaurizio Rossini, Roberta Zanotti, Ombretta Viapiana, et al.
Therapeutic Advances in Musculoskeletal Disease|November 28, 2022
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosisRiccardo Bixio, Giovanni Adami, Eugenia Bertoldo, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
BMC Rheumatology|September 10, 2024
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritisGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|July 12, 2018
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitisGiovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Pharmacological Research|July 16, 2019
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritisGiovanni Orsolini, Angelo Fassio, Maurizio Rossini, et al.
Cancers|December 24, 2021
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM NetworkRoberta Zanotti, Massimiliano Bonifacio, Cecilia Isolan, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Clinical and Experimental Rheumatology|December 2, 2014
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral densityMaurizio Rossini, Ombretta Viapiana, Silvano Adami, et al.
Clinical and Experimental Rheumatology|October 3, 2019
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunctionGiovanni Cioffi, Alessandro Giollo, Giovanni Orsolini, et al.
The American Journal of Medicine|June 24, 2014
Zoledronic acid in osteoporosis secondary to mastocytosisMaurizio Rossini, Roberta Zanotti, Ombretta Viapiana, et al.
Therapeutic Advances in Musculoskeletal Disease|November 28, 2022
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosisRiccardo Bixio, Giovanni Adami, Eugenia Bertoldo, et al.
Pageof 8